Viewing Study NCT07408804

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-06-02 @ 2:04 PM
Study NCT ID: NCT07408804
Status: RECRUITING
Last Update Posted: 2026-02-13
First Post: 2026-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Comparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma
Sponsor: Bangladesh Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable Hepatocellular Carcinoma (HCC) View
Keywords: